FreeThink is proud to introduce OzmoCAP®, the extended release capsule.
Last week, FreeThink exhibited its new proprietary technology at the Controlled Release Society Annual Meeting and Expo in Montreal.
OzmoCAP® is an oral extended release osmotic capsule that provides a range of drug release durations controlled by the capsule, not the drug’s properties. With OzmoCAP® technology, FreeThink now has the capability to produce capsules to support animal studies to establish proof of concept. FreeThink’s OzmoCAP® technical team can develop, produce, and ship filled capsules with client active ingredients of known release rates in a matter of weeks.
For more information on OzmoCAP® and its advantages, visit OzmoCAP.com.
Photo caption: From left, Business Development Manager Dave Lucey and Technology Development Lead Dr. Jennifer Chu exhibit OzmoCAP® at this year’s CRS Expo.